Therapeutic Reference Pricing
Therapeutic Reference Pricing is a health policy mechanism that groups pharmaceutical products by therapeutic equivalence to establish a maximum reimbursement level, distinguishing itself from broader pricing strategies by aligning cost containment with clinical interchangeability within the same therapeutic class.
27
Publications
1.1K
Citations
67
Authors
43
Institutions
Publications per year
2017–2026
3
Parents
27
Anthony M. DiGioia, Pamela K. Greenhouse, Michelle L. Giarrusso et al. · The Journal of Arthroplasty · 2015 · 61 citations
Health Professions, Orthopaedic Surgery, Orthopedic Surgery +17
1–5 of 27
67
6
h-index
5
h-index
4
h-index
3
h-index
3
h-index
1–5 of 67
43
Harvard University
Cambridge, United States
7 h-index
17 publications
1.3K citations

Brigham and Women's Hospital
Boston, United States
4 h-index
7 publications
440 citations
Harvard Pilgrim Health Care
Boston, United States
3 h-index
3 publications
225 citations
Ministry of Health
Victoria, Canada
2 h-index
3 publications
396 citations
United BioSource Corporation (United Kingdom)
London, United Kingdom
2 h-index
3 publications
57 citations

McMaster University
Hamilton, Canada
2 h-index
2 publications
86 citations
Research Institute Hospital 12 de Octubre
Madrid, Spain
1 h-index
1 publications
13 citations

University of Toronto
Toronto, Canada
1 h-index
1 publications
25 citations
1–8 of 43
Repository · 7 publications · 294 citations
7
h-index
4 publications · 134 citations
4
h-index
NEJM · 2 publications · 209 citations
2
h-index
HSR · 1 publications · 47 citations
1
h-index
Repository · 1 publications · 13 citations
1
h-index
1–5